Expression of aurora kinase A correlates with the Wnt‐modulator RACGAP 1 in gastric cancer-Reference-Cited by-同舟云学术

Expression of aurora kinase A correlates with the Wnt‐modulator RACGAP 1 in gastric cancer

Published:2016-01-18 Issue:3 Volume:5 Page:516-526
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Bornschein Jan¹,Nielitz Jessica¹,Drozdov Ignat²,Selgrad Michael¹,Wex Thomas¹³,Jechorek Doerthe⁴,Link Alexander¹,Vieth Michael⁴⁵,Malfertheiner Peter¹

Affiliation:

1. Department of Gastroenterology, Hepatology and Infectious Diseases Otto‐von‐Guericke University Leipziger Str. 44 39120 Magdeburg Germany

2. Department of Computational Biology Bering Limited 80 Third Cross Road Twickenham TW2 5EA United Kingdom

3. Department of Molecular Genetics Medical Laboratory for Clinical Chemistry, Microbiology and Infectious Diseases Am Neustädter Feld 47 39124 Magdeburg Germany

4. Institute of Pathology Otto‐von‐Guericke University Leipziger Str. 44 39120 Magdeburg Germany

5. Institute of Pathology Klinikum Bayreuth GmbH Preuschwitzer Str. 101 95445 Bayreuth Germany

Funder

Seventh Framework Programme

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.610

Reference48 articles.

1. The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

3. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

4. Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs

5. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased PTCHD4 expression via m6A modification of PTCHD4 mRNA promotes senescent cell survival;Nucleic Acids Research;2024-05-09

2. Oncogenic and immunological roles of RACGAP1 in pan-cancer and its potential value in nasopharyngeal carcinoma;Apoptosis;2023-09-05

3. Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway;Frontiers in Pharmacology;2023-03-01

4. Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression;Aging and disease;2023

5. Role of AURKA in the hypothalamus–pituitary–testicular axis in Tibetan sheep from Tianzhu;General and Comparative Endocrinology;2021-01